<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02278107</url>
  </required_header>
  <id_info>
    <org_study_id>JM-001-2014</org_study_id>
    <nct_id>NCT02278107</nct_id>
  </id_info>
  <brief_title>Evaluation of a Lightweight Nasal Interface and Ventilator in Patients With Respiratory Disease</brief_title>
  <official_title>Evaluation of a Lightweight Nasal Interface and Ventilator for Use by Patients With Respiratory Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New Aera, Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>New Aera, Inc</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A preliminary study to evaluate a new nasal interface and portable ventilator system in
      comparison to standard oxygen therapy in patients with severe chronic lung disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      An open-label, randomized, controlled, crossover study in patients with severe chronic lung
      disease to evaluate exercise tolerance compared to standard nasal cannula oxygen therapy.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>July 2014</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Exercise Endurance Time to Maximum Tolerance</measure>
    <time_frame>Maximum exercise endurance in minutes, for both treatment arms. Two 4-hr study visits, 1 week apart. Endurance endpoint will be evaluated during a single 4-hr period on Study Visit 2. Each exercise test will be separated by a 1.5 hr rest period.</time_frame>
    <description>Endurance measured on cycle ergometer at predetermined constant work rate. Subjects will exercise to their limit of tolerability (max effort).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Borg 10 Dyspnea Score, Subject reported</measure>
    <time_frame>Recorded 1-2 min before and every 1 min during exercise testing. Two 4-hr study visits, scheduled 1 week apart. Endpoint will be evaluated during a single 4-hr period on Study Visit 2. Each exercise test will be separated by a 1.5 hr rest period.</time_frame>
    <description>10 point Analog scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial Oxygen Saturation via Pulse Oximeter (SpO2)</measure>
    <time_frame>Recorded 1-2 min before and every 1 minute during exercise testing. Two 4-hr study visits, scheduled 1 week apart. Endpoint will be evaluated during a single 4-hr period on Study Visit 2. Each exercise test will be separated by a 1.5 hr rest period.</time_frame>
    <description>SpO2 measured via forehead and finger pulse oximeters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Leg Fatigue, Subject Reported</measure>
    <time_frame>Recorded 1-2 min before and every 1 min during exercise testing. Two 4-hr study visits, scheduled 1 week apart. Endpoint will be evaluated during a single 4-hr period on Study Visit 2. Each exercise test will be separated by a 1.5 hr rest period.</time_frame>
    <description>10 point Analog scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate</measure>
    <time_frame>Recorded 1-2 min before and every 1 min during exercise testing. Two 4-hr study visits, scheduled 1 week apart. Endpoint will be evaluated during a single 4-hr period on Study Visit 2. Each exercise test will be separated by a 1.5 hr rest period.</time_frame>
    <description>Heart rate recorded by pulse oximeters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Rate</measure>
    <time_frame>Recorded 1-2 min before and every 1 min during exercise. Evaluated during a single 4-hr period on Study Visit 2. Each exercise test will be separated by a 1.5 hr rest period.</time_frame>
    <description>Respiratory rate recorded by observer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>Two 4-hr study visits, sheduled 1 week apart. Subjects will be monitored for AEs continuously throughuout the study visit. AEs will be monitored and recored during both study visits.</time_frame>
    <description>Monitoring for observed or reported adverse reactions</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Chronic Obstructive Lung Disease</condition>
  <condition>Interstitial Lung Disease</condition>
  <arm_group>
    <arm_group_label>Tidal Assist Ventilator System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lightweight, portable, positive pressure ventilator system with proprietary nasal interface. Ventilator is powered by compressed oxygen delivered by cylinder, concentrator, or wall source.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nasal Cannula Oxygen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nasal Cannula Oxygen Standard nasal cannula oxygen at 2-5 liters per minute (LPM) based on patient requirement. Oxygen sources includes cylinder, concentrator, or wall source.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tidal Assist Ventilator System</intervention_name>
    <description>Tidal volume augmentation with supplemental oxygen. Source gas options: cylinder, concentrator, wall.</description>
    <arm_group_label>Tidal Assist Ventilator System</arm_group_label>
    <other_name>TAV</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nasal Cannula Oxygen</intervention_name>
    <description>Standard oxygen therapy delivered by nasal cannula at 2-5 lpm based on patient requirements. Source gas options: cylinder, concentrator, wall.</description>
    <arm_group_label>Nasal Cannula Oxygen</arm_group_label>
    <other_name>Standard oxygen therapy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult male or female (&gt; 18 years of age) with a diagnosis of severe-to-very severe
             chronic lung disease

          -  Participates in a qualified pulmonary rehabilitation program

          -  Requires constant flow oxygen of â‰¥ 2 LPM (liters per minute) during exercise

          -  Able and willing to sign the informed consent

          -  Ability to be fitted with the test nasal mask and to use the test ventilator system

        Exclusion Criteria:

          -  Requires &gt; 5LPM of constant flow to maintain SpO2&gt; 90% during exercise

          -  Reports having serious epistaxis within the last 14 days prior to enrollment

          -  Currently enrolled in another clinical study or has participated within 30 days of
             enrollment

          -  Has any condition or abnormality that in the opinion of the Investigators may
             compromise the participant's safety or the quality of the study data
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Kops, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>John Muir Medical Center, Concord Campus</affiliation>
  </overall_official>
  <reference>
    <citation>Porszasz J, Cao R, Morishige R, van Eykern LA, Stenzler A, Casaburi R. Physiologic effects of an ambulatory ventilation system in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013 Aug 1;188(3):334-42. doi: 10.1164/rccm.201210-1773OC.</citation>
    <PMID>23741986</PMID>
  </reference>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 23, 2014</study_first_submitted>
  <study_first_submitted_qc>October 27, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 29, 2014</study_first_posted>
  <last_update_submitted>February 26, 2016</last_update_submitted>
  <last_update_submitted_qc>February 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Interstitial</mesh_term>
    <mesh_term>Respiration Disorders</mesh_term>
    <mesh_term>Respiratory Tract Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

